Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $92.65 | Total: $463.25 |
| 1 | 10 | $78.48 | Total: $784.80 |
| 1 | 25 | $66.49 | Total: $1,662.25 |
| 1 | 50 | $56.68 | Total: $2,834.00 |
| 1 | 100 | $49.05 | Total: $4,905.00 |
Overview
Elgodipine significantly reduced the incidence and severity of exercise-induced angina pectoris systemically and was able to inhibit vascular smooth muscle proliferation through a mechanism independent of the expression of the transcription factors c-fos and c-jun. The Elgodipine-induced inhibition was voltage-dependent. Elgodipine is a potential compound for the treatment of angina pectoris.
Chemical Properties
| Molecular Formula | C29H33FN2O6 |
| Molecular Weight | 524.58 |
| CAS Numbers | 119413-55-7 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C(OCCN(CC1=CC=C(F)C=C1)C)(=O)C=2C(C(C(OC(C)C)=O)=C(C)NC2C)C3=C4C(=CC=C3)OCO4 |
Storage and Handling
0C Short Term, -20C Long Term
References
Tamargo J, et al. Cardiovascular effects of the new dihydropyridine derivative elgodipine. Arzneimittelforschung. 1991;41[9] 895-900.